<?xml version="1.0" encoding="UTF-8"?>
<p>Data from the current COVID-19 pandemic are limited. One study among patients with diabetes and COVID-19 reported that preprandial and postprandial glucose levels were above target in 29.4% and 64.5%, respectively, whereas 10% suffered at least 1 hypoglycemic event [
 <xref rid="CIT0099" ref-type="bibr">99</xref>]. Details of their antidiabetic therapies, outcomes, or comparison with a control group were not reported. Anecdotal reports from experts caring for COVID-19 patients note a higher incidence of hyperglycemia, new-onset diabetes, diabetic ketoacidosis, and euglycemic ketoacidosis [
 <xref rid="CIT0100" ref-type="bibr">100</xref>].
</p>
